A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.
about
Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial.High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function.Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models.Social Cognition Deficits: Current Position and Future Directions for Neuropsychological Interventions in Cerebrovascular Disease.PGC-1α provides a transcriptional framework for synchronous neurotransmitter release from parvalbumin-positive interneurons.Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationGenetic Modifiers for Neuromuscular DiseasesAttenuation of polyglutamine-induced toxicity by enhancement of mitochondrial OXPHOS in yeast and fly models of aging.Genetic modifiers of Huntington's disease.Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease.Balancing the Demands of Two Tasks: An Investigation of Cognitive-Motor Dual-Tasking in Relapsing Remitting Multiple Sclerosis.Repeated Assessment and Practice Effects of the Written Symbol Digit Modalities Test Using a Short Inter-Test Interval.Simplified method to obtain enhanced expression of tau protein from E. coli and one-step purification by direct boiling.Cell-specific deletion of PGC-1α from medium spiny neurons causes transcriptional alterations and age-related motor impairment.Changes in dual-task performance after 5 months of karate and fitness training for older adults to enhance fall prevention.Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.A Mitochondria-Associated Oxidative Stress Perspective on Huntington's DiseaseStratifying Heterogeneous Dimension of Neurodegenerative Diseases: Intervention for Stipulating Epigenetic Factors to Combat Oxidative Stress in Human BrainNon-motor Behavioral Alterations of PGC-1α-Deficient Mice - A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression
P2860
Q29994702-7F168A81-14C1-4C43-8BB5-05386C87BA7AQ33562672-CC3853C3-2A58-493E-BAD2-0115349F93E8Q33729341-0449B324-6CC3-4D47-B22C-18F6CC85DE8EQ33907409-F07E1A0C-0FD6-487E-AF85-11441A8A3F10Q34383492-1804D28C-F4E8-4D13-8301-20CA46140DECQ34944325-EB2E94AE-B5D8-42D0-B9D7-1E7DC5EAC380Q35119976-B1832A68-FA2F-4590-B9D4-6005A2E86DD0Q37698147-F4137603-8842-405F-8EA7-609849085179Q38243002-9698802F-3F63-4D24-8ECB-BC45FC27A9BAQ41721818-5C23CE39-C9F5-4CC1-99CB-BC79FA27DD1CQ45302304-EA9CA226-BEF2-4E42-9C2C-3033BA32EABBQ47762418-4552935A-420C-464E-8669-8DFAE021EA10Q48668774-7372AE3F-F84B-4745-ABA6-97476C980687Q50261748-3D9455EA-941F-4E0F-BFAA-135C06AEF043Q50421506-CE76BB4D-9355-41B3-964C-A2AB09B052BCQ53251148-537233C3-37A2-428F-8DBE-12B0B09EB921Q54965657-73BD54F6-C696-476F-9CA6-AE1C8C28737EQ55081064-CDA97ED7-993B-4D87-BE88-CC294DEEBCB1Q57072860-34FC0492-9F4A-4AD0-A5B1-2A853C879B61Q58051863-40CA02D9-BAB3-4005-9D17-AB364F5D6DC2Q58700726-7B1B85C1-5DC1-46C0-9D14-A578183ECD77
P2860
A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A single nucleotide polymorphi ...... et in a large European cohort.
@ast
A single nucleotide polymorphi ...... et in a large European cohort.
@en
type
label
A single nucleotide polymorphi ...... et in a large European cohort.
@ast
A single nucleotide polymorphi ...... et in a large European cohort.
@en
prefLabel
A single nucleotide polymorphi ...... et in a large European cohort.
@ast
A single nucleotide polymorphi ...... et in a large European cohort.
@en
P2093
P2860
P356
P1433
P1476
A single nucleotide polymorphi ...... set in a large European cohort
@en
P2093
European Huntington Disease Network
Patrick Weydt
Selma M Soyal
Wolfgang Patsch
P2860
P2888
P356
10.1186/1471-2377-14-1
P577
2014-01-02T00:00:00Z
P5875
P6179
1049118707